Skip to content
Catalyst

3beta-hydroxyandrost-5-en-17-oneFinding

3beta-hydroxyandrost‑5-en‑17-one has no detected effect on postprandial blood glucose area under the curve

no difference foundModerate evidenceFinding

01 · The sentence it was drawn from

“Changes in the areas under the curve for glucose and insulin did not differ significantly between the placebo group (panels A and B) and the DHEA group (panels C and D) (glucose, p=0.09; insulin, p=0.52).”
Quoted verbatim from Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans.
This finding among the 3 findings on its endpoint

3beta-hydroxyandrost-5-en-17-one

Postprandial blood glucose area under the curve

no difference found

Who
men and women aged 65-75 without known diabetes (16 found diabetic on the baseline OGTT and kept in); multivitamin and calcium/vitamin D supplements given to both arms
Dose studied
50 mg DHEA once daily for 12 months

Moderate evidencePMID 21566261 · 2011

02 · The study

Study
RCT
Duration
12 months

Evidence, by strength

  • strong
  • moderatethis finding
  • limited
  • very limited
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M7GY9RVWF1S4F1HGF1D4NRB6